
|Articles|August 22, 2013
- The Column-08-22-2013
- Volume 9
- Issue 15
An Insight into Analytical Quality by Design in the Pharmaceutical Industry
Kate Mosford of The Column spoke to Rosario LoBrutto of Teva about the business of analytical QbD, the steps involved in implementing it, and advice to those who want to get started.
Advertisement
Kate Mosford of The Column spoke to Rosario LoBrutto of Teva about the business of analytical QbD, the steps involved in implementing it, and advice to those who want to get started.
Articles in this issue
over 12 years ago
The 2013 LCGC Awards: Part 2over 12 years ago
Pattern Recognitionover 12 years ago
Helium Supply: The Search For AlternativeNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Navigating Adverse Reactions in GLP-1 Treatment
2
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Advancing RNA-Based Therapeutics: IQ Consortium Experts on Optimizing Chromatographic Bioanalysis
5





